Breast Cancer Risk Factors in Women
Last month, we looked at two different types of genetic variants: BRCA variants and the KRAS-variant. Both BRCA and KRAS are pathogenic variants that are linked to an increased risk of breast…
Read More ➝
Posts
Understanding different genetic causes of cancer: BRCA variants vs. the KRAS-variant
This post explores BRCA variants vs. the KRAS-variant and is part two of our series on understanding the different genetic causes of cancer. In part one of our series, we compared genetic…
Read More ➝
Genetic variants vs. genetic mutations: understanding the different causes of cance
Learn more about how our genes play a role in cancer development in this two-part series comparing different genetic variants and genetic mutations. Genes and cancer development: Gene Variants vs Mutations Cancer…
Read More ➝
Gennev Podcast Recap: MHT, Breast Cancer, Estrogen, and Menopause
Want to learn more about menopause, menopausal hormone therapy (MHT), formerly hormone replacement therapy (HRT), estrogen, and breast cancer risk? Why not sit down, pop in some headphones, and listen to this…
Read More ➝
Clinical Trial for Patients with the KRAS-variant and HNSCC
Here on MiraKind.org, we’ve already discussed how the KRAS-variant plays a role in breast cancer risk, ovarian cancer risk, effects of MHT in the KRAS-variant patients, and even autoimmunity! Now, we want…
Read More ➝
Let’s learn more about Menopausal Hormone Therapy – together!
We want to start with the basics about Menopausal Hormone Therapy (MHT) so you can get up to speed on the importance of MiraKind’s new study. In this article, we’ll cover what…
Read More ➝
More proof Menopausal Hormone Therapy (MHT) is safe, effective, and beneficial for most women
When our team came across a recent Los Angeles Times Article entitled, “Once and for all: Hormone replacement is good for women” we were very intrigued. What we learned from this game-changing…
Read More ➝
If I participate in a study will you send me my KRAS-variant results?
We had an excellent question from a MiraKind study participant. They wanted to know, “If I participate in a study will you send me my KRAS-variant results?” Unfortunately, the answer is no….
Read More ➝
Do I need to get tested for KRAS-variant if I’m BRCA positive?
We received a great question from a friend of a patient asking, “since she knows she has a BRCA mutation, is it necessary to find out if she also has the KRAS-variant?…
Read More ➝
Should I Get Pelvic Exams if I Have No Ovaries?
We had an excellent question from a participant who has the KRAS-variant and had chosen to have her ovaries removed. She asked her OB/GYN if she still needed to have pelvic exams…
Read More ➝
New Research: How Inherited DNA -Based Mutations Impact Immunotherapy
The partners on the UCLA research team have made new discoveries about how genetic mutations can help doctors predict patient responses to cancer-fighting immunotherapy drugs. In the past, we have spoken a…
Read More ➝
Menopause & Myths about Menopausal Hormone Therapy
Post Updated February 7, 2022 For the large majority of us who suffer one or more symptoms of menopause, we can all agree that it is NO FUN. So what can we…
Read More ➝
What You Need to Know About Estrogen and the KRAS-variant
Joanne Weidhaas is MiraKind’s founder and one of the scientists responsible for discovering the KRAS-variant, an inherited genetic mutation that predicts an increased risk of cancer. Following this breakthrough, Dr. Weidhaas and…
Read More ➝
Let’s Talk Menopause (Finally)
Menopause: a condition that 100% of women will experience, yet so few of us feel comfortable talking about. We all know something about menopause, but just like pregnancy or bungee jumping, you…
Read More ➝The KRAS-Variant and Breast Cancer: Understanding Genetic Risk
Last updated: 11/25/2025 Most people are familiar with BRCA1 and BRCA2, the genes best known for their link to hereditary breast cancer. Discoveries of these mutations have offered important clues about inherited…
Read More ➝- « Previous
- 1
- 2
- 3
- 4
- Next »
